Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;14MG | 1 | NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
002 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;28MG | 1 | NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
003 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;7MG | 1 | NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
004 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;21MG | 1 | NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
FDA Submissions
TYPE 4; Type 4 - New Combination | ORIG | 1 | AP | 2014-12-23 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2015-10-06 | STANDARD |
EFFICACY; Efficacy | SUPPL | 3 | AP | 2016-07-18 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 15 |
CDER Filings
ALLERGAN
cder:Array
(
[0] => Array
(
[ApplNo] => 206439
[companyName] => ALLERGAN
[docInserts] => ["",""]
[products] => [{"drugName":"NAMZARIC","activeIngredients":"DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE","strength":"10MG;14MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"NAMZARIC","activeIngredients":"DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE","strength":"10MG;28MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"NAMZARIC","activeIngredients":"DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE","strength":"10MG;7MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"NAMZARIC","activeIngredients":"DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE","strength":"10MG;21MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"07\/18\/2016","submission":"SUPPL-3","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206439s003lbl.pdf\"}]","notes":""},{"actionDate":"12\/23\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/206439lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"12\/23\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/206439lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/206439Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/206439Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/206439Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"07\/18\/2016","submission":"SUPPL-3","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206439s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/206439Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"10\/06\/2015","submission":"SUPPL-2","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/01\/2015","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2016-07-18
)
)